Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques
SCIE
SCOPUS
- Title
- Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques
- Authors
- Kim, JH; Ha, TL; Im, GH; Yang, J; Seo, SW; Chung, JJ; Chae, SY; Lee, IS; Lee, JH
- Date Issued
- 2014-03-05
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Abstract
- In this study, we have shown the potential of a voxel-based analysis for imaging amyloid plaques and its utility in monitoring therapeutic response in Alzheimer's disease (AD) mice using manganese oxide nanoparticles conjugated with an antibody of A beta 1-40 peptide (HMON-abA beta 40). T1-weighted MR brain images of a drug-treated AD group (n=7), a nontreated AD group (n=7), and a wild-type group (n=7) were acquired using a 7.0 T MRI system before (D-1), 24-h (D+1) after, and 72-h (D+3) after injection with an HMON-abA beta 40 contrast agent. For the treatment of AD mice, DAPT was injected intramuscularly into AD transgenic mice (50 mg/kg of body weight). For voxel-based analysis, the skull-stripped mouse brain images were spatially normalized, and these voxels' intensities were corrected to reduce voxel intensity differences across scans in different mice. Statistical analysis showed higher normalized MR signal intensity in the frontal cortex and hippocampus of AD mice over wild-type mice on D+1 and D+3 (P < 0.01, uncorrected for multiple comparisons). After the treatment of AD mice, the normalized MR signal intensity in the frontal cortex and hippocampus decreased significantly in comparison with nontreated AD mice on D+1 and D+3 (P < 0.01, uncorrected for multiple comparisons). These results were confirmed by histological analysis using a thioflavin staining. This unique strategy allows us to detect brain regions that are subjected to amyloid plaque deposition and has the potential for human applications in monitoring therapeutic response for drug development in AD.
- Keywords
- magnetic resonance imaging; hollow manganese oxide nanoparticles; amyloid plaque; Alzheimer' s disease; therapeutic response; MANGANESE OXIDE NANOPARTICLES; MILD COGNITIVE IMPAIRMENT; IN-VIVO; MICE; IMAGES; PET
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/13819
- DOI
- 10.1097/WNR.0000000000000067
- ISSN
- 0959-4965
- Article Type
- Article
- Citation
- NEUROREPORT, vol. 25, no. 4, page. 211 - 218, 2014-03-05
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.